What is the analyst consensus rating for ALNY?

The analyst consensus rating for ALNY is "Buy" based on 14 analyst recommendations.

What is the average price target for ALNY?

The average 12-month price target for ALNY is $410.07, representing an upside of 37.4% from the current price of $298.48.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Alnylam Pharmaceuticals, Inc. (ALNY) Forecast: Analyst Ratings & Targets

Latest ALNY Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Apr 13, 2026	Danielle Brill	Truist	Maintains	Strong Buy	$515.00 → $505.00 -10.00 (-1.9%)
Mar 25, 2026	Keay Nakae	Chardan Capital	Maintains	Strong Buy	$425.00 → $425.00 +0.00 (0.0%)
Mar 25, 2026	Whitney Ijem	Canaccord Genuity	Maintains	Buy	$429.00
Mar 25, 2026	Patrick R. Trucchio	HC Wainwright	Reiterates	Strong Buy	$510.00 → $510.00 +0.00 (0.0%)
Mar 25, 2026	Kostas Biliouris	Oppenheimer	Reiterates	Buy	$500.00
Mar 24, 2026	Salveen Richter	Goldman Sachs	Maintains	Buy	$580.00 → $549.00 -31.00 (-5.3%)
Mar 24, 2026	Tazeen Ahmad	BofA Securities	Maintains	Buy	$462.00 → $460.00 -2.00 (-0.4%)
Mar 16, 2026	Faisal Khurshid	Jefferies	Downgrades	Hold	$522.00 → $330.00 -192.00 (-36.8%)
Mar 15, 2026	Faisal Khurshid	Jefferies	Upgrades	Hold	$330.00
Mar 5, 2026	Google Biotechnology	TipRanks - Google	Reiterates	Buy	$349.00 → $362.00 +13.00 (3.7%)
Mar 5, 2026	PerPlexity Biotechnology	TipRanks - PerPlexity	Reiterates	Hold	$322.00 → $338.00 +16.00 (5.0%)
Mar 5, 2026	Anthropic Biotechnology	TipRanks - Anthropic	Reiterates	Hold	$319.00 → $331.00 +12.00 (3.8%)
Mar 5, 2026	DeepSeek Biotechnology	TipRanks - DeepSeek	Reiterates	Hold	$324.00 → $339.00 +15.00 (4.6%)
Mar 5, 2026	xAi Biotechnology	TipRanks - xAI	Reiterates	Hold	$312.00 → $333.00 +21.00 (6.7%)
Mar 5, 2026	OpenAI Biotechnology	TipRanks - OpenAI	Reiterates	Hold	$316.00 → $330.00 +14.00 (4.4%)

Danielle Brill

Truist

Strong BuyMaintains

$515.00 → $505.00

Apr 13

Keay Nakae

Chardan Capital

Strong BuyMaintains

$425.00 → $425.00

Mar 25

Whitney Ijem

Canaccord Genuity

BuyMaintains

$429.00

Mar 25

Patrick R. Trucchio

HC Wainwright

Strong BuyReiterates

$510.00 → $510.00

Mar 25

Kostas Biliouris

Oppenheimer

BuyReiterates

$500.00

Mar 25

Salveen Richter

Goldman Sachs

BuyMaintains

$580.00 → $549.00

Mar 24

Tazeen Ahmad

BofA Securities

BuyMaintains

$462.00 → $460.00

Mar 24

Faisal Khurshid

Jefferies

HoldDowngrades

$522.00 → $330.00

Mar 16

Faisal Khurshid

Jefferies

HoldUpgrades

$330.00

Mar 15

Google Biotechnology

TipRanks - Google

BuyReiterates

$349.00 → $362.00

Mar 5

PerPlexity Biotechnology

TipRanks - PerPlexity

HoldReiterates

$322.00 → $338.00

Mar 5

Anthropic Biotechnology

TipRanks - Anthropic

HoldReiterates

$319.00 → $331.00

Mar 5

DeepSeek Biotechnology

TipRanks - DeepSeek

HoldReiterates

$324.00 → $339.00

Mar 5

xAi Biotechnology

TipRanks - xAI

HoldReiterates

$312.00 → $333.00

Mar 5

OpenAI Biotechnology

TipRanks - OpenAI

HoldReiterates

$316.00 → $330.00

Mar 5

Alnylam Pharmaceuticals, Inc. (ALNY) Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest ALNY Analyst Ratings & Recommendations

Frequently Asked Questions